Revive Therapeutics Provides Update on its Clinical Development Plan For Rare Liver Diseases

NEXT STORY
Inventiva admitted to the SRD “Long only” on the regulated market of Euronext Paris
PREV STORY
PharmaCyte Biotech Set to Reach Three Major Milestones in 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hemispherx Biopharma Signs Clinical Trial Agreement with Roswell Park Comprehensive Cancer Center to Study Ampligen in Combination with Checkpoint Inhibitors in a Phase IIa Study in Urothelial Carcinoma, Renal Cell Carcinoma and Melanoma

New Agreement Expands Existing Preclinical CollaborationsOCALA, Fla., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Hemispherx ...

author_avatar
NASDAQ Market News

Novo Nordisk submits application in the US for including data from the DEVOTE trial in the Tresiba® label

Bagsværd, Denmark, 27 May 2017 - Novo Nordisk today announced the submission of a ...

author_avatar
NASDAQ Market News

Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021

author_avatar
NASDAQ Market News